Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$663K Sell
12,641
-534
-4% -$28.2K 0.06% 207
2026
Q1
$727K Hold
13,175
0.07% 185
2025
Q4
$646K Hold
13,175
0.07% 189
2025
Q3
$569K Buy
+13,175
New +$515K 0.06% 199
2019
Q1
Sell
-911
Closed -$44K 273
2018
Q4
$44K Hold
911
0.02% 214
2018
Q3
$46K Buy
911
+183
+25% +$9.3K 0.02% 212
2018
Q2
$37K Hold
728
0.01% 223
2018
Q1
$36K Sell
728
-118
-14% -$5.5K 0.01% 217
2017
Q4
$38K Hold
846
0.01% 200
2017
Q3
$43K Buy
846
+118
+16% +$5.99K 0.02% 203
2017
Q2
$39K Sell
728
-1,600
-69% -$85.3K 0.02% 197
2017
Q1
$123K Buy
+2,328
New +$118K 0.05% 135

Other funds holding GSK

Heritage Trust's GSK Position: Q2 2026 in Review

Heritage Trust reduced its GSK (GSK) stake by 4.1% in Q2 2026, selling an estimated $28.2K and leaving 12,641 shares worth $663K. The position accounts for 0.06% of the portfolio, ranked #207.

Heritage Trust first reported a position in GSK in Q1 2017 and has held it in 12 quarters since. The position peaked at $727K in Q1 2026. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Heritage Trust held 12,641 shares of GSK worth $663K as of Q2 2026.
  • Heritage Trust sold 534 GSK shares in Q2 2026, an estimated $28.2K.
  • GSK made up 0.06% of Heritage Trust's portfolio in Q2 2026, its #207 holding.
  • Heritage Trust first reported a position in GSK in Q1 2017 and has held it in 12 quarters since.
  • Heritage Trust's GSK position peaked at $727K in Q1 2026.
  • 1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Heritage Trust's 13F filing for Q2 2026, filed 6 Aug 2026.